Ratio of serum eosinophil cationic protein/blood eosinophil counts in children with asthma: Comparison between acute exacerbation and clinical remission

Allergy and Asthma Proceedings

Volumn 24, Issue 4, 2003, Pages 269-274

  Koh, Young Yull ^a   Kang, Hee ^a   Kim, Chang Keun ^b  

^a Seoul National University Hospital   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BLOOD CELL COUNT; CHILD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; EOSINOPHIL; FEMALE; HUMAN; MALE; MEDICAL ASSESSMENT; PROTEIN BLOOD LEVEL; REMISSION; SPIROMETER;

ACUTE DISEASE; ASTHMA; CHILD; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; REMISSION, SPONTANEOUS;

EID: 0141628507     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 85:422-436, 1990.
2. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 323:1033-1039, 1990.
3. Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 142:434-457, 1990.
4. Laitinen LA, Laitinen A, Heino M, et al. Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid. Am Rev Respir Dis 143:423-427, 1991.
5. Horn BR, Robin ED, Theodore J, et al. Total eosinophil counts in the management of bronchial asthma. N Engl J Med 292:1152-1155, 1975.
6. Ulrik CS. Peripheral eosinophil counts as a marker of disease activity in intrinsic and extrinsic asthma. Clin Exp Allergy 25:820-827, 1995.
7. 1. Cross-sectional and longitudinal analyses. Am Rev Respir Dis 143:987-992, 1991.
8. Taylor KJ, and Luksza AR. Peripheral blood eosinophil counts and bronchial responsiveness. Thorax 42:452-456, 1987.
9. Gleich GJ, Flavahan NA, Fujisawa T, et al. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J Allergy Clin Immunol 81:776-781, 1988.
10. Venge P. Soluble markers of allergic inflammation. Allergy 49:1-8, 1994.
11. Niimi A, Amitani R, Suzuki K, et al. Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma. Clin Exp Allergy 28:233-240, 1998.
12. 20, and exacerbations. Respir Med 88:613-621, 1994.
13. Zimmerman B, Lanner A, Enander I, et al. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin Exp Allergy 23:564-570, 1993.
14. Lee MH, Lee JH, Park CH, et al. Serum eosinophil cationic protein levels and bronchodilator responses at acute asthma exacerbation. Ann Allergy Asthma Immunol 79:363-369, 1997.
15. Tang R-B, and Chen S-J. Serum levels of eosinophil cationic protein and eosinophils in asthmatic children during a course of prednisolone therapy. Pediatr Pulmonol 31:121-125, 2001.
16. Sheffer AL. Guidelines for the diagnosis and management of asthma. I. Definition and diagnosis. J Allergy Clin Immunol 88:427-438, 1991.
17. Yoon KA, Lim HS, Koh YY, et al. Normal predicted values of pulmonary function test in Korean school-aged children. J Korean Pediatr Assoc 36:25-37, 1993.
18. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136:225-243, 1987.
19. Venge P. Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma. Clin Exp Allergy 23:3-7, 1993.
20. Hoekstra MO, Hovenga H, Gerritsen J, et al. Eosinophils and eosinophil-derived proteins in children with moderate asthma. Eur Respir J 9:2231-2235, 1996.
21. Fujitaka M, Kawaguchi H, Kato Y, et al. Significance of the eosinophil cationic protein/eosinophil count ratio in asthmatic patients: its relationship to disease severity. Ann Allergy Asthma Immunol 86:323-329, 2001.
22. Imai C, Yamazaki H, Tanaka Y, et al. Ratio of eosinophil cationic protein/eosinophil count as a new marker in children with acute asthma. Pediatr Int 41:142-146, 1999.
23. Wempe JB, Tammeling EP, Koeter GH, et al. Blood eosinophil number and activity during 24 hours: effects of treatment with budesonide and bambuterol. J Allergy Clin Immunol 90:757-765, 1992.
24. Juntunen-Backman K, Jarvinen P, and Sorva RJ. Serum eosinophil cationic protein during treatment of asthma in children. J Allergy Clin Immunol 92:34-38, 1993.
25. Kuo H-P, Yu T-R, and Yu C-T. Hypodense eosinophil number relates to clinical severity, airway hyperresponsiveness and response to inhaled corticosteroids in asthmatic subjects. Eur Respir J 7:1452-1459, 1994.
26. Adolphson CR, and Gleich GJ. Eosinophils. In Allergy. Holgate ST, and Church MK (Eds). London: Gower Medical, 6.1-6.12, 1993.
27. Venge P, Bystrom J, Carlson M, et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 29:1172-1186, 1999.
28. Carlson M, Peterson C, and Venge P. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation. Allergy 48:437-442, 1993.
29. Hoglund M, Simonsson B, Smedmyr B, et al. The effect of rGM-CSF on neutrophil and eosinophil regeneration after ABMT as monitored by circulating levels of granule proteins. Br J Haematol 86:709-716, 1994.
30. Shaver JR, Zangrilli JG, Cho S-K, et al. Kinetics of the development and recovery of the lung from IgE-mediated inflammation: dissociation of pulmonary eosinophilia, lung injury, and eosinophil-active cytokines. Am J Respir Crit Care Med 155:442-448, 1997.